CheckMate 436: Extended follow-up from the phase 2 study investigating nivolumab plus brentuximab vedotin (BV) for relapsed/refractory primary mediastinal large B-cell lymphoma (R/R PMBL) Meeting Abstract
| Authors: | Zinzani, P. L.; Santoro, A.; Gritti, G.; Brice, P.; Barr, P.; Cunningham, D.; Kline, J.; Johnson, N.; Mehta-Shah, N.; Fanale, M.; Francis, S.; Moskowitz, A. |
| Abstract Title: | CheckMate 436: Extended follow-up from the phase 2 study investigating nivolumab plus brentuximab vedotin (BV) for relapsed/refractory primary mediastinal large B-cell lymphoma (R/R PMBL) |
| Meeting Title: | 9th Annual Meeting of the Society of Hematologic Oncology (SOHO) |
| Keywords: | immunotherapy; combination therapy; non-hodgkin lymphoma; primary mediastinal b-cell lymphoma; abcl |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 21 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2021 Sep 8-11 |
| Meeting Location: | Virtual event |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2021-09-01 |
| Start Page: | S398 |
| End Page: | S399 |
| Language: | English |
| ACCESSION: | WOS:000691910500339 |
| PROVIDER: | wos |
| DOI: | 10.1016/s2152-2650(21)01901-7 |
| Notes: | Meeting Abstract: ABCL-454 -- Source: Wos |
